Literature DB >> 21308525

Drug-Resistant Malaria: The Era of ACT.

Jessica T Lin1, Jonathan J Juliano, Chansuda Wongsrichanalai.   

Abstract

As drug-resistant falciparum malaria has continued to evolve and spread worldwide, <span class="Chemical">artemisinin-based combination therapies (ACT) have become the centerpiece of global malaria control over the past decade. This review discusses how advances in antimalarial drug resistance monitoring and rational use of the array of ACTs now available can maximize the impact of this highly efficacious therapy, even as resistance to artemisinins is emerging in Southeast Asia.

Entities:  

Year:  2010        PMID： 21308525      PMCID： PMC3058555          DOI： 10.1007/s11908-010-0099-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  43 in total

Review 1.  Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.

Authors:  H Bukirwa; J Critchley
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

3.  Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.

Authors:  Mey Bouth Denis; Reiko Tsuyuoka; Pharath Lim; Niklas Lindegardh; Poravuth Yi; Sophoan Narann Top; Duong Socheat; Thierry Fandeur; Anna Annerberg; Eva Maria Christophel; Pascal Ringwald
Journal:  Trop Med Int Health       Date:  2006-12       Impact factor: 2.622

4.  The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure.

Authors:  Colin J Sutherland; Christopher J Drakeley; Uche Obisike; Rosalind Coleman; Musa Jawara; Geoffrey A T Targett; Paul Milligan; Margaret Pinder; Gijs Walraven
Journal:  Am J Trop Med Hyg       Date:  2003-07       Impact factor: 2.345

5.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

6.  The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.

Authors:  Christin Sisowath; Pedro E Ferreira; Leyla Y Bustamante; Sabina Dahlström; Andreas Mårtensson; Anders Björkman; Sanjeev Krishna; José P Gil
Journal:  Trop Med Int Health       Date:  2007-06       Impact factor: 2.622

7.  Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.

Authors:  Mayke J A M Oesterholt; Michael Alifrangis; Colin J Sutherland; Sabah A Omar; Patrick Sawa; Christina Howitt; Louis C Gouagna; Robert W Sauerwein; Teun Bousema
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

8.  Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs.

Authors:  Jianbing Mu; Rachel A Myers; Hongying Jiang; Shengfa Liu; Stacy Ricklefs; Michael Waisberg; Kesinee Chotivanich; Polrat Wilairatana; Srivicha Krudsood; Nicholas J White; Rachanee Udomsangpetch; Liwang Cui; May Ho; Fengzhen Ou; Haibo Li; Jianping Song; Guoqiao Li; Xinhua Wang; Suon Seila; Sreng Sokunthea; Duong Socheat; Daniel E Sturdevant; Stephen F Porcella; Rick M Fairhurst; Thomas E Wellems; Philip Awadalla; Xin-zhuan Su
Journal:  Nat Genet       Date:  2010-01-31       Impact factor: 38.330

9.  Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.

Authors:  Moses R Kamya; Adoke Yeka; Hasifa Bukirwa; Myers Lugemwa; John B Rwakimari; Sarah G Staedke; Ambrose O Talisuna; Bryan Greenhouse; François Nosten; Philip J Rosenthal; Fred Wabwire-Mangen; Grant Dorsey
Journal:  PLoS Clin Trials       Date:  2007-05-18

10.  The rationale and plan for creating a World Antimalarial Resistance Network (WARN).

Authors:  Carol Hopkins Sibley; Karen I Barnes; Christopher V Plowe
Journal:  Malar J       Date:  2007-09-06       Impact factor: 2.979
View more
  40 in total

Review 1.  Can pharmacogenomics improve malaria drug policy?

Authors:  Mary W Roederer; Howard McLeod; Jonathan J Juliano
Journal:  Bull World Health Organ       Date:  2011-09-01       Impact factor: 9.408

Review 2.  Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum.

Authors:  Connor O'Brien; Philipp P Henrich; Neha Passi; David A Fidock
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

3.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Methodological approaches for analysing data from therapeutic efficacy studies.

Authors:  Solange Whegang Youdom; Leonardo K Basco
Journal:  Malar J       Date:  2021-05-21       Impact factor: 2.979

5.  MK-4815, a potential new oral agent for treatment of malaria.

Authors:  Mary Ann Powles; John Allocco; Lai Yeung; Bakela Nare; Paul Liberator; Dennis Schmatz
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

Review 6.  Resisting resistance: gearing up for war.

Authors:  Aurijit Sarkar; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2019-08-07       Impact factor: 3.597

7.  Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screen.

Authors:  Laura M Sanz; M Belen Jiménez-Díaz; Benigno Crespo; Cristina De-Cozar; M Jesus Almela; Iñigo Angulo-Barturen; Pablo Castañeda; Javier Ibañez; Esther Pilar Fernández; Santiago Ferrer; Esperanza Herreros; Sonia Lozano; María Santos Martínez; Lourdes Rueda; Jeremy N Burrows; Jose F García-Bustos; Francisco-Javier Gamo
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

8.  In vitro sensitivity to antimalarial drugs and polymorphisms in Pfg377 gene in Plasmodium falciparum field isolates from Mewat, India.

Authors:  Vineeta Singh; Amit Kumar; Purva Gupta
Journal:  Pathog Glob Health       Date:  2017-06-12       Impact factor: 2.894

9.  The Investment Case for Malaria Elimination in Thailand: A Cost-Benefit Analysis.

Authors:  Prayuth Sudathip; Darin Kongkasuriyachai; Rachel Stelmach; Donal Bisanzio; Jeffrey Sine; Surasak Sawang; Suravadee Kitchakarn; David Sintasath; Richard Reithinger
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

10.  Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.

Authors:  Divya Sharma; Manila Lather; Cherry L Dykes; Amita S Dang; Tridibes Adak; Om P Singh
Journal:  Parasitol Res       Date:  2015-09-26       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.